Retrospective study to assess the efficacy and safety of checkpoint inhibitors in advanced urothelial carcinoma in real-world setting.

被引：0
|
作者：
Sevillano Fernandez, Elena
Puente, Javier
Vidal, Natalia
Pinto, Alvaro
Garcia Sanchez, Lourdes
Fiorini, Aldo
Chara Velarde, Luis Enrique
Nalda Ariza, Irene
Cassinello, Javier
Rodriguez, Angel
Galvan Ruiz, Saray
Francisco Rodriguez-Moreno, Juan
Barquin, Arantzazu
Ruiz, Sergio
Navarro, Paloma
Yague, Monica
Grande, Enrique
Garcia-Donas, Jesus
机构：
[1] HM Hosp, Madrid, Spain
[2] Hosp Univ Clin San Carlos, Madrid, Spain
[3] Hosp Clin San Carlos, Madrid, Spain
[4] La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain
[5] Hosp Gen Segovia, Segovia, Spain
[6] Hosp Univ Guadalajara, Guadalajara, Spain
[7] Hosp Leon, Leon, Spain
[8] Hosp Univ Gran Canaria Doctor Negrin, Med Oncol Unit, Las Palmas Gran Canaria, Spain
[9] HM Hosp Ctr Integral Oncol Clara Campal, Madrid, Spain
[10] Lab Translat Oncol CIOCC, Madrid, Spain
[11] MD Anderson Canc Ctr, Madrid, Spain
[12] Fdn Hosp Madrid, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17043
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effect of body mass index (BMI) on efficacy of immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) in real-world setting.
    Lynn, David
    Dawsey, Scott
    Hobeika, Charbel
    Patgunarajah, Ubenthira
    Pramod, Nikhil
    Wei, Wei
    Nair, Monica
    Maroli, Kimberly
    Martin, Allison
    Ornstein, Moshe Chaim
    Wee, Christopher Eing
    Gilligan, Timothy D.
    Nizam, Amanda
    Bonham, Amanda
    Mian, Omar Y.
    Pavicic, Paul G., Jr.
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Genomic correlates of response and resistance to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting.
    Pramod, Nikhil
    Makarov, Vladimir
    Dawsey, Scott
    Pavicic, Paul G.
    Patgunarajah, Ubenthira
    Nair, Monica
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Wee, Christopher Eing
    Nizam, Amanda
    Mian, Omar Y.
    Nguyen, Jane
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 670 - 670
  • [3] Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study
    Su, Ruopeng
    Chen, Zeyu
    Hong, Daoping
    Jiang, Shuai
    Yuan, Yichu
    Cai, Xingyun
    Hu, Hailong
    Fu, Changde
    Huang, Zhiyang
    Wang, Zhenyu
    Zheng, Bing
    Huang, Jian
    Wang, Zaoyu
    Bao, Yige
    Cai, Ming
    Guo, Jianming
    Chen, Minfeng
    Wei, Qiang
    Huang, Jiwei
    Xue, Wei
    [J]. CANCER MEDICINE, 2023, 12 (09): : 10587 - 10596
  • [4] The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
    Obi, Shuntaro
    Sato, Takahisa
    Sato, Shinpei
    Kanda, Miho
    Tokudome, Yuta
    Kojima, Yuichiro
    Suzuki, Yoji
    Hosoda, Kenji
    Kawai, Toshihiro
    Kondo, Yuji
    Isomura, Yoshihiro
    Ohyama, Hiroshi
    Nakagomi, Keiko
    Ashizawa, Hiroshi
    Miura, Yuko
    Amano, Hiroyuki
    Mochizuki, Hitoshi
    Omata, Masao
    [J]. HEPATOLOGY INTERNATIONAL, 2019, 13 (02) : 199 - 204
  • [5] The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
    Shuntaro Obi
    Takahisa Sato
    Shinpei Sato
    Miho Kanda
    Yuta Tokudome
    Yuichiro Kojima
    Yoji Suzuki
    Kenji Hosoda
    Toshihiro Kawai
    Yuji Kondo
    Yoshihiro Isomura
    Hiroshi Ohyama
    Keiko Nakagomi
    Hiroshi Ashizawa
    Yuko Miura
    Hiroyuki Amano
    Hitoshi Mochizuki
    Masao Omata
    [J]. Hepatology International, 2019, 13 : 199 - 204
  • [6] Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian center
    Ng, Kennedy
    Wong, Lawrence Wen Jun
    Choo, Su Pin
    Tai, David Wai-Meng
    Tan, Sze Huey
    Ang, Andrea Jing Shi
    Lee, Joycelyn Jie Xin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [7] Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center
    Ng, Kennedy Yao Yi
    Wong, Lawrence Wen Jun
    Ang, Andrea Jing Shi
    Tan, Sze Huey
    Choo, Su Pin
    Tai, David Wai-Meng
    Lee, Joycelyn Jie Xin
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (05) : E249 - E261
  • [8] The effect of antibiotic (Abx) use on immune checkpoint inhibitor (ICI) efficacy in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting.
    Patgunarajah, Ubenthira
    Dawsey, Scott
    Pramod, Nikhil
    Maroli, Kimberly
    Ornstein, Moshe Chaim
    Wee, Christopher Eing
    Gilligan, Timothy D.
    Martin, Allison
    Nizam, Amanda
    Mian, Omar Y.
    Wei, Wei
    Diaz-Montero, C. Marcela
    Pavicic, Paul G.
    Nguyen, Jane
    Gupta, Shilpa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in China: A retrospective, real-world study.
    Yang, Xin-Rong
    Guo, De-Zhen
    Chen, Fei-Yu
    Fan, Jia
    Jian, Zhou
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Effect of neutrophil to lymphocyte ratio (NLR) on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in real-world setting.
    Lynn, David
    Dawsey, Scott
    Patgunarajah, Ubenthira
    Pramod, Nikhil
    Wei, Wei
    Hobeika, Charbel
    Nair, Monica
    Maroli, Kimberly
    Martin, Allison
    Ornstein, Moshe Chaim
    Wee, Christopher Eing
    Gilligan, Timothy D.
    Nizam, Amanda
    Bonham, Amanda
    Mian, Omar Y.
    Pavicic, Paul G.
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 678 - 678
12345